Qi X, Guo X. Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies. Gastroenterology Review/Przegląd Gastroenterologiczny. 2015;10(3):142-147. doi:10.5114/pg.2015.52470.
APA
Qi, X., & Guo, X. (2015). Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies. Gastroenterology Review/Przegląd Gastroenterologiczny, 10(3), 142-147. https://doi.org/10.5114/pg.2015.52470
Chicago
Qi, Xingshun, and Xiaozhong Guo. 2015. "Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies". Gastroenterology Review/Przegląd Gastroenterologiczny 10 (3): 142-147. doi:10.5114/pg.2015.52470.
Harvard
Qi, X., and Guo, X. (2015). Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies. Gastroenterology Review/Przegląd Gastroenterologiczny, 10(3), pp.142-147. https://doi.org/10.5114/pg.2015.52470
MLA
Qi, Xingshun et al. "Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 10, no. 3, 2015, pp. 142-147. doi:10.5114/pg.2015.52470.
Vancouver
Qi X, Guo X. Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies. Gastroenterology Review/Przegląd Gastroenterologiczny. 2015;10(3):142-147. doi:10.5114/pg.2015.52470.
